Literature DB >> 9621081

Costimulatory pathways in lymphocyte proliferation induced by the simian immunodeficiency virus SIVsmmPBj14.

L Whetter1, F J Novembre, M Saucier, S Gummuluru, S Dewhurst.   

Abstract

The PBj14 isolate of the simian immunodeficiency virus SIVsmmPBj14 is unique among primate lentiviruses in its ability to induce lymphocyte proliferation and acutely lethal disease. The studies reported here show that viral induction of T-cell proliferation requires accessory cells, such as primary monocytes or Raji B-lymphoma cells, as well as the presence of a putative immunoreceptor tyrosine-based activation motif within the viral Nef protein. Addition of CTLA4-immunoglobulin fusion protein or anti-B7 antibodies to virally infected T cells led to substantial, but not complete, inhibition of monocyte-costimulated T-cell proliferation-suggesting that both CD28/B7-dependent and non-CD28-dependent pathways may contribute to the costimulation of virally induced lymphoproliferation. Finally, cyclosporin A, a specific inhibitor of the calcium-calmodulin-regulated phosphatase activity of calcineurin, which influences activation of the transcription factor nuclear factor of activated T cells, was shown to block virally mediated T-cell proliferation. Taken together, these findings suggest that the effect of SIVsmmPBj14 on T-cell activation may be functionally analogous, at least in part, to the effect of engagement of the T-cell receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621081      PMCID: PMC110423     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.

Authors:  M Ott; S Emiliani; C Van Lint; G Herbein; J Lovett; N Chirmule; T McCloskey; S Pahwa; E Verdin
Journal:  Science       Date:  1997-03-07       Impact factor: 47.728

Review 2.  The mechanism of action of cyclosporin A and FK506.

Authors:  S Ho; N Clipstone; L Timmermann; J Northrop; I Graef; D Fiorentino; J Nourse; G R Crabtree
Journal:  Clin Immunol Immunopathol       Date:  1996-09

3.  Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant SIVmac239.

Authors:  V G Sasseville; Z Du; L V Chalifoux; D R Pauley; H L Young; P K Sehgal; R C Desrosiers; A A Lackner
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

4.  p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes.

Authors:  G J Russell; C M Parker; A Sood; E Mizoguchi; E C Ebert; A K Bhan; M B Brenner
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 5.  Accessory molecule and costimulation requirements for CD4 T cell response.

Authors:  M Croft; C Dubey
Journal:  Crit Rev Immunol       Date:  1997       Impact factor: 2.214

Review 6.  Making the T cell receptor go the distance: a topological view of T cell activation.

Authors:  A S Shaw; M L Dustin
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

7.  MRC OX-2 defines a novel T cell costimulatory pathway.

Authors:  F Borriello; J Lederer; S Scott; A H Sharpe
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

8.  Apoptosis correlates with immune activation in intestinal lymphoid tissue from macaques acutely infected by a highly enteropathic simian immunodeficiency virus, SIVsmmPBj14.

Authors:  S Gummuluru; F J Novembre; M Lewis; H A Gelbard; S Dewhurst
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

9.  Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production.

Authors:  G Aversa; C C Chang; J M Carballido; B G Cocks; J E de Vries
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

10.  Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons.

Authors:  M T Wong; M J Dolan; E Kozlow; R Doe; G P Melcher; D S Burke; R N Boswell; M Vahey
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

View more
  4 in total

1.  Biologic studies of chimeras of highly and moderately virulent molecular clones of simian immunodeficiency virus SIVsmPBj suggest a critical role for envelope in acute AIDS virus pathogenesis.

Authors:  M Haddrick; C R Brown; R Plishka; A Buckler-White; V M Hirsch; H Ginsberg
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj.

Authors:  S Hodge; J de Rosayro; A Glenn; I C Ojukwu; S Dewhurst; H M McClure; N Bischofberger; D C Anderson; S A Klumpp; F J Novembre
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.

Authors:  Xiaoduan Weng; Elena Priceputu; Pavel Chrobak; Johanne Poudrier; Denis G Kay; Zaher Hanna; Tak W Mak; Paul Jolicoeur
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.